Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Myeloproliferative Disorders × Rivaroxaban × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Venous Thromboembolism 4 Treatment of Venous Thromboembolism in Cancer Patients 3 Neoplasms 3 Venous Thrombosis 1 Pulmonary Embolism 1 Myeloproliferative Disorders 1 Embolism 1

Interventions

Blood Specimen Collection 6 Flow Cytometry 4 Polymerase Chain Reaction 3 Watchful Waiting 2 Therapeutics 2 Microarray Analysis 2 Immunoenzyme Techniques 2 Amplified Fragment Length Polymorphism Analysis 2 edoxaban 1 apixaban 1 X-Rays 1 Valganciclovir 1 Tinzaparin 1 Surveys and Questionnaires 1 Standard of Care 1 Rivaroxaban 1 Reverse Transcriptase Polymerase Chain Reaction 1 Psychiatric Rehabilitation 1 Pharmaceutical Preparations 1 Peripheral Blood Stem Cell Transplantation 1 Observation 1 Magnetic Resonance Imaging 1 Immunologic Techniques 1 Gene Expression Profiling 1 Ganciclovir 1 Foscarnet 1 Fentanyl 1 Electrophoresis, Polyacrylamide Gel 1 Echocardiography 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04192916 2021-02-21

MPN-DOACs

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡